We’re learning more about human papillomavirus (HPV), long known as a risk factor for cervical cancer and other sexually transmitted tumors. According to The Healthy, new research now points to certain HPV types—especially those spreading through skin contact—as possible contributors to squamous cell carcinoma, a type of skin cancer.
What Is HPV and Why Is It So Common?
HPV is one of the most widespread viral infections worldwide, including in Hungary. A 2025 U.S. report shows that the vast majority of people—over 80% of women and 90% of men—will be infected with at least one HPV strain at some point in their lives.
There are more than 200 known HPV types, several of which can cause tumors. The most recognized are those linked to cervical cancer, but some HPV strains also play a role in cancers of the anus, penis, throat, and mouth.
What Do the New Studies Suggest?
Recently, a U.S. research team studied a notable case: a 34-year-old woman with recurring skin cancer lesions on her forehead tested positive for a skin-transmitted HPV type called beta-HPV.
Researchers observed that the virus integrated into the tumor cells’ DNA and produced viral proteins, which may have contributed to tumor growth and weakened immune response.
The patient underwent an experimental stem cell transplant that restored her immune function, after which the tumors regressed.
Dr. Andrea Lisco, who led the case study, believes this finding offers a fresh perspective on understanding squamous cell carcinoma, especially in people with weakened immune systems. It’s important to note: this is a unique case and not broadly generalizable, but it encourages further research.
What Is Beta-HPV?
Different HPV types behave differently. Beta-HPV can spread without sexual contact, through skin-to-skin contact—even during everyday interactions. A German study found beta-HPV on people’s skin or hair follicles, even without visible symptoms. Some research shows this virus in up to 80% of skin samples.
Does This Pose a Risk?
It’s key to understand that HPV infection alone doesn’t necessarily lead to tumors. In most cases, the immune system clears the virus without causing illness.
However, certain conditions—like weakened immunity—can allow some HPV strains to contribute to cancer development.
Why Is Vaccination Important?
HPV vaccination is available in Hungary for people aged 9 to 45. The vaccine protects against cervical cancer and other tumors linked to high-risk HPV types. While there’s no targeted vaccine yet for skin-spreading beta-HPV, experts believe strengthening the immune system and protecting against HPV overall can reduce the risk of other cancers in the long run.
How Can We Prevent It?
Getting the HPV vaccine early—ideally before any infection—can be a smart move.
- Regular screenings, like gynecological exams, help catch issues early.
- Support your immune system with balanced nutrition, enough sleep, and stress management.
- See a dermatologist if you notice any persistent skin lesions, wounds, or growths.
Our understanding of HPV keeps evolving. The latest research hints that HPV isn’t just linked to genital cancers but may also play a role in some skin cancers. While more studies are needed, taking prevention seriously—through vaccination, healthy living, and regular medical check-ups—is a powerful way to protect yourself.
